STOCK TITAN

Cyrusone (CONE) Stock Price, News & Analysis

CONE NASDAQ

Company Description

Cyrusone (NASDAQ: CONE) is classified in the reit—specialty industry within the Real Estate sector and carries a market capitalization of $11.9B.

This page collects what Stock Titan holds for CONE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
-
-
Last updated:
-
Performance 1 year
$11.9B

Latest News

Cyrusone has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. Key topics include management, acquisition, earnings. View all CONE news →

SEC Filings

Cyrusone has filed 1 recent SEC filing, including 1 Form 425. The most recent filing was submitted on June 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CONE SEC filings →

Financial Highlights

Revenue (latest FY)
Net Income (latest FY)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CONE Company Profile & Sector Positioning

Cyrusone (CONE) operates in the REIT—Specialty industry within the broader Real Estate sector and is listed on the NASDAQ.

Investors comparing CONE often look at related companies in the same sector, including Host Hotels (HST), Camden Ppty Tr (CPT), Lamar Advertising Co (LAMR), Omega Healthcare (OHI), and Healthpeak Properties Inc (DOC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CONE's relative position within its industry.

Frequently Asked Questions

What is the market cap of Cyrusone (CONE)?

The market cap of Cyrusone (CONE) is approximately 11.9B. Learn more about what market capitalization means .